Trial reportBMC oral health2026
Molecular analysis of intracanal microbial reduction to compare the effectiveness of glycyrrhizin and calcium hydroxide as intracanal medications: a randomised controlled trial.
Trial report in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06291623 (Molecular Analysis of Intracanal Microbes After Chemomechanical Procedure and Root Canal Medication), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Molecular Analysis of Intracanal Microbes After Chemomechanical Procedure and Root Canal Medication: A Randomized Controlled Trial
Who cites it
2 citing papers in PubMed.
- Effect of simvastatin versus calcium hydroxide intracanal medications on postoperative pain and cytokine modulation in symptomatic apical periodontitis: a randomized controlled trial.BMC oral health · 2026Trial
- Influence of Obturation Technique on the Retreatability and Push-Out Bond Strength of Bioceramic Sealers: An In Vitro SEM Study.Materials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndodontic treatment aims to thoroughly clean and disinfect the root canal system; however, current techniques, instruments, and irrigants limit complete root canal sterilisation. This study aimed to assess and compare the antibacterial effectiveness of glycyrrhizin (Gly) and calcium hydroxide (Ca(OH)2) as intracanal medicaments using molecular analysis.
methodsThis double-blind (participant- and assessor-blind) study included 28 patients with single-rooted teeth diagnosed with pulp necrosis and asymptomatic apical periodontitis. Following field disinfection, bacterial samples were collected before and after chemomechanical preparation (S1 and S2, respectively) and 7 days after intracanal medicament placement (S3). Participants were randomly assigned to Group 1 (Ca(OH)2) or Group 2 (Gly) (n = 14 each). All samples were promptly transferred for molecular analysis, and bacterial DNA and RNA levels were assessed using real-time polymerase chain reaction. Data were log-transformed and evaluated using mixed‑effects two‑way repeated‑measures models (time × treatment). The change in log‑transformed DNA and RNA between S2 and S3 (Δlog S3–S2) was compared between groups using the Mann–Whitney U test, with a significance level of 0.05.
resultsTwenty-eight participants (14 per group) were included in the statistical analysis at S1, S2. At S3, data were available for 10 and 11 participants for DNA and 11 and 10 participants for RNA in groups 1 and 2, respectively. Mixed‑effects two‑way repeated‑measures analysis showed significant effects of group and time on log‑transformed bacterial DNA and RNA levels, with a significant group×time interaction (p < 0.0001). The reduction in log‑transformed RNA (primary end-point) and DNA from S2 to S3 (Δlog S3–S2) was significantly greater in Group 2 than in Group 1 (RNA: p < 0.0001; DNA: p = 0.0004).
conclusionsCompared with Ca(OH)2, Gly demonstrated greater antibacterial activity through greater reductions in bacterial DNA and RNA levels. This may support the potential of Gly as an alternative intracanal medicament during root canal therapy.
trial registrationThis study was retrospectively registered on clinicaltrials.gov under the identifier NCT06291623 on March 4, 2024.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.